{"id":1163,"date":"2026-08-08T10:00:00","date_gmt":"2026-08-08T10:00:00","guid":{"rendered":"https:\/\/medycyna-gorska.pl\/?p=1163"},"modified":"2026-08-08T10:00:00","modified_gmt":"2026-08-08T10:00:00","slug":"nifedipine-hape-prophylaxis","status":"publish","type":"post","link":"https:\/\/medycyna-gorska.pl\/en\/nifedipine-hape-prophylaxis\/","title":{"rendered":"Nifedipine for HAPE \u2014 Rescue Drug and Re-entry Prophylaxis"},"content":{"rendered":"\n

Nifedipine<\/strong> is a calcium channel blocker from the dihydropyridine class \u2014 most often associated with hypertension and Prinzmetal’s angina treatment. In mountain medicine, however, it is the first-line<\/em> drug for high-altitude pulmonary edema (HAPE)<\/strong>. It acts by dilating pulmonary vessels and lowering pressure in the pulmonary circulation, directly reducing the mechanism of fluid leak into alveoli. This article: rescue dosing, when nifedipine does NOT replace descent, interactions, prophylaxis in high-risk individuals.<\/p>\n\n\n\n

Nifedipine in a nutshell<\/h2>\n\n\n\n
    \n
  • Mechanism<\/strong>: L-type calcium channel blocker \u2014 dilates pulmonary vessels, lowers pulmonary artery pressure<\/li>\n
  • HAPE treatment<\/strong>: 30 mg retard every 12 h or 20 mg retard every 8 h<\/li>\n
  • HAPE prophylaxis<\/strong> in high-risk: 20 mg retard every 12 h starting 24 h before ascent<\/li>\n
  • Re-entry HAPE<\/strong> (recurrent each ascent): mandatory prophylaxis<\/li>\n
  • Does NOT replace descent<\/strong> \u2014 buys 4\u20138 h for evacuation<\/li>\n
  • Contraindications<\/strong>: cardiogenic shock, aortic stenosis, recent MI (<1 mo), first trimester pregnancy<\/li>\n<\/ul>\n\n\n\n

    Mechanism in HAPE<\/h2>\n\n\n\n

    HAPE develops through the sequence: hypoxia \u2192 pulmonary vasoconstriction \u2192 rise in pulmonary artery pressure \u2192 damage to capillary barrier \u2192 fluid leak into alveoli. Nifedipine interrupts this mechanism at the second step \u2014 dilates pulmonary vessels, lowers pulmonary artery pressure by 15\u201330%, directly reducing the driving force for leak.<\/p>\n\n\n\n

    Unlike dexamethasone (which acts through barrier stabilization and inflammation reduction \u2014 slower, hours), nifedipine acts quickly<\/strong> \u2014 hemodynamic effect in 30 min, peak 1\u20132 h. Therefore it is the tactical drug in acute HAPE.<\/p>\n\n\n\n

    HAPE treatment dosing<\/h2>\n\n\n\n

    Extended-release form (preferred)<\/h3>\n\n\n\n

    Nifedipine 30 mg extended-release (retard) every 12 h<\/strong> \u2014 classic regimen recommended by Wilderness Medical Society 2019. Alternative: 20 mg retard every 8 h<\/strong>, if smaller tablets available.<\/p>\n\n\n\n

    Treatment duration: until descent to low altitude + 24 h observation. Typically 2\u20134 days. Do not discontinue the drug until saturation normalizes (>92% at sea level) and symptoms resolve.<\/p>\n\n\n\n

    Immediate-release form (emergency)<\/h3>\n\n\n\n

    Immediate-release nifedipine tablets \u2014 10 mg oral dose. Not routinely recommended<\/strong> in HAPE, because rapid systemic blood pressure drop can cause reflex tachycardia and myocardial ischemia. Use only when retard is unavailable and you are awaiting evacuation.<\/p>\n\n\n\n

    Prophylaxis in high-risk individuals<\/h2>\n\n\n\n

    Nifedipine is the only drug with documented efficacy in HAPE prevention. B\u00e4rtsch RCT (NEJM 1991): prophylactic nifedipine 20 mg retard every 8 h reduced HAPE frequency in persons with history of HAPE<\/strong> from 70% to 10%.<\/p>\n\n\n\n

    Prophylaxis indications<\/h3>\n\n\n\n
      \n
    • History of HAPE<\/strong> (re-entry HAPE) \u2014 absolute indication<\/li>\n
    • History of HACE<\/strong> with concurrent HAPE<\/li>\n
    • Rescuers forced to rapid ascent<\/strong> >4000 m \u2014 consider<\/li>\n
    • People with pulmonary hypertension<\/strong> (cardiac defect, COPD) \u2014 cardiology consultation pre-expedition<\/li>\n<\/ul>\n\n\n\n

      Prophylactic dosing<\/h3>\n\n\n\n

      Nifedipine 20 mg retard every 12 h<\/strong>, started 24 h before ascending above 3500 m, continued until full acclimatization or descent. Some protocols use 30 mg retard once daily (after confirmed good tolerance).<\/p>\n\n\n\n

      Note:<\/strong> nifedipine prophylaxis does NOT exempt from the 300\u2013500 m\/day rule. It supplements proper acclimatization, not replaces it.<\/p>\n\n\n\n

      Side effects<\/h2>\n\n\n\n
        \n
      • Systemic blood pressure drop<\/strong> \u2014 in some significant; dizziness, weakness on standing (orthostasis)<\/li>\n
      • Reflex tachycardia<\/strong> \u2014 body compensates for pressure drop; usually 10\u201320 beats\/min higher<\/li>\n
      • Facial flushing<\/strong> \u2014 cutaneous vasodilation<\/li>\n
      • Headache<\/strong> \u2014 paradoxically common from cerebral vasodilation<\/li>\n
      • Lower limb edema<\/strong> \u2014 peripheral vasodilation<\/li>\n
      • Gastric discomfort<\/strong> \u2014 nausea, heartburn<\/li>\n<\/ul>\n\n\n\n

        Most side effects are mild and resolve after few days. If symptoms (especially orthostasis) are bothersome \u2014 reduce dose or discontinue prophylaxis.<\/p>\n\n\n\n

        Contraindications<\/h2>\n\n\n\n
          \n
        • Cardiogenic shock<\/strong> \u2014 absolute<\/li>\n
        • Recent myocardial infarction<\/strong> (<1 month) \u2014 absolute<\/li>\n
        • Unstable angina<\/strong><\/li>\n
        • Severe aortic stenosis<\/strong> \u2014 afterload reduction may worsen flow<\/li>\n
        • Hypertrophic cardiomyopathy with outflow obstruction<\/strong><\/li>\n
        • Pregnancy \u2014 first trimester<\/strong> (class C\/D)<\/li>\n
        • Severe hepatic insufficiency<\/strong> \u2014 hepatic metabolism<\/li>\n
        • Dihydropyridine allergy<\/strong><\/li>\n<\/ul>\n\n\n\n

          Drug interactions<\/h2>\n\n\n\n
            \n
          • Grapefruit juice<\/strong> \u2014 CYP3A4 inhibitor, significant nifedipine concentration increase (2\u20133\u00d7) = hypotension. Avoid during treatment.<\/li>\n
          • Sildenafil (Viagra) and other PDE5<\/strong> \u2014 additive hypotensive effect, potentially severe hypotension. Absolutely avoid combination<\/strong>.<\/li>\n
          • Other antihypertensives<\/strong> (ACE-I, ARB, beta-blockers, diuretics) \u2014 amplify pressure drop<\/li>\n
          • Rifampicin, phenytoin, carbamazepine<\/strong> \u2014 induce CYP3A4, may weaken nifedipine action<\/li>\n
          • Digoxin<\/strong> \u2014 nifedipine slightly increases digoxin concentration (monitor in cardiac patients)<\/li>\n<\/ul>\n\n\n\n

            Nifedipine vs alternatives in HAPE<\/h2>\n\n\n\n

            Tadalafil (Cialis)<\/h3>\n\n\n\n

            PDE5 inhibitor \u2014 alternative with newer data. Prophylactic dose: 10 mg once daily<\/strong>. Advantages: longer action (36 h), once-daily dosing, milder side effect profile. Disadvantages: higher cost, prescription required, don’t combine with nitrates and PDE5.<\/p>\n\n\n\n

            Sildenafil<\/h3>\n\n\n\n

            Shorter duration than tadalafil (4\u20136 h), requires 3 doses daily (50 mg). Less practical for expedition prophylaxis. Mainly used in pulmonary hypertension treatment.<\/p>\n\n\n\n

            Dexamethasone<\/h3>\n\n\n\n

            Not first-line in HAPE (that’s for HACE), but may be added as adjunctive therapy in severe HAPE with suspected cerebro-pulmonary edema component. Dose as in HACE (8 mg + 4 mg every 6 h).<\/p>\n\n\n\n

            Frequently asked questions<\/h2>\n\n\n
            \n
            \n
            \n

            Does nifedipine replace descent in HAPE?<\/h3>\n
            \n\n

            No. Nifedipine lowers pulmonary artery pressure and slows HAPE mechanism but doesn’t treat the cause \u2014 hypoxia. Buys 4\u20138 h for evacuation and improves saturation. Only effective HAPE treatment is descent + oxygen. Nifedipine + oxygen + descent = standard. Without descent symptoms return after drug effect wanes.<\/p>\n\n<\/div>\n<\/div>\n

            \n

            Which nifedipine form in HAPE \u2014 retard or immediate?<\/h3>\n
            \n\n

            Preferred: retard (extended-release) 30 mg every 12 h or 20 mg every 8 h. Retard provides stable drug levels and lower hypotension risk than immediate-release. Immediate-release (10 mg) only in emergency without retard \u2014 administer orally, not sublingually (sublingual can cause acute hypotension).<\/p>\n\n<\/div>\n<\/div>\n

            \n

            Can I take nifedipine prophylactically without HAPE history?<\/h3>\n
            \n\n

            Not recommended. Nifedipine prophylaxis is documented only in persons with HAPE history (re-entry HAPE) \u2014 efficacy 70% \u2192 10% there. For others acetazolamide is preferred (broader acclimatization action, fewer side effects). If HAPE history \u2014 absolutely. If not \u2014 acetazolamide + gradual ascent suffices.<\/p>\n\n<\/div>\n<\/div>\n

            \n

            Nifedipine and acetazolamide interactions \u2014 can combine?<\/h3>\n
            \n\n

            Yes, safe and often recommended in severe cases. Acetazolamide acts through compensatory hyperventilation (better saturation), nifedipine through pulmonary vasodilation (less leak). Mechanisms are complementary. Dosing unchanged: acetazolamide 125\u2013250 mg twice daily + nifedipine 30 mg retard every 12 h. Both hypotensive, monitor BP first 24 h.<\/p>\n\n<\/div>\n<\/div>\n

            \n

            Cost of nifedipine in expedition kit?<\/h3>\n
            \n\n

            In Poland: nifedipine retard 20 mg (30 tabs) \u2014 ~15\u201320 PLN; retard 30 mg \u2014 ~20\u201330 PLN; immediate 10 mg \u2014 ~10\u201315 PLN. Prescription required. HAPE rescue kit (10 retard 20 mg tabs) costs a few dollars and should be in every kit for expeditions above 4000 m.<\/p>\n\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n

            References<\/h2>\n\n\n\n
              \n
            • B\u00e4rtsch P, Maggiorini M, Ritter M, et al. Prevention of high-altitude pulmonary edema by nifedipine<\/em>. N Engl J Med. 1991;325(18):1284\u20131289.<\/li>\n
            • Luks AM, Auerbach PS, Freer L, et al. Wilderness Medical Society Clinical Practice Guidelines: 2019 Update<\/em>. Wilderness Environ Med. 2019;30(4S):S3\u2013S18.<\/li>\n
            • Maggiorini M, Brunner-La Rocca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema<\/em>. Ann Intern Med. 2006;145(7):497\u2013506.<\/li>\n<\/ul>\n\n\n\n

              Disclaimer:<\/strong> Nifedipine is a prescription drug. Use only after consultation with an expedition medicine physician. This article is educational.<\/em><\/p>\n\n","protected":false},"excerpt":{"rendered":"

              Nifedipine in HAPE: mechanism (pulmonary vasodilation), 30 mg retard every 12 h, re-entry HAPE prophylaxis, contraindications, grapefruit\/PDE5 interactions.<\/p>\n","protected":false},"author":2,"featured_media":747,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-1163","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aktualnosci"],"_links":{"self":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts\/1163","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/comments?post=1163"}],"version-history":[{"count":1,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts\/1163\/revisions"}],"predecessor-version":[{"id":1313,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/posts\/1163\/revisions\/1313"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/media\/747"}],"wp:attachment":[{"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/media?parent=1163"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/categories?post=1163"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medycyna-gorska.pl\/en\/wp-json\/wp\/v2\/tags?post=1163"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}